DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer.
<h4>Background</h4>Induction chemotherapy is a common therapeutic option for patients with locoregionally-advanced head and neck cancer (HNC), but it remains unclear which patients will benefit. In this study, we searched for biomarkers predicting the response of patients with locoregion...
Main Authors: | Tanguy Y Seiwert, XiaoZhe Wang, Jana Heitmann, Vivian Villegas-Bergazzi, Kam Sprott, Stephen Finn, Esther O'Regan, Allan D Farrow, Ralph R Weichselbaum, Mark W Lingen, Ezra E W Cohen, Kerstin Stenson, David T Weaver, Everett E Vokes |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25019640/?tool=EBI |
Similar Items
-
Unmasking the tumourigenic role of SIN1/MAPKAP1 in the mTOR complex 2
by: Emilien Ezine, et al.
Published: (2023-10-01) -
Xpf suppresses the mutagenic consequences of phagocytosis in Dictyostelium
by: Pontel, LB, et al.
Published: (2016) -
XPF activates break-induced telomere synthesis
by: Chia-Yu Guh, et al.
Published: (2022-10-01) -
A new negative feedback mechanism for MAPK pathway inactivation through Srk1 MAPKAP kinase
by: Maribel Marquina, et al.
Published: (2022-11-01) -
MAPKAP1 rs10118570 polymorphism is associated with anti-infection and anti-hepatic fibrogenesis in schistosomiasis japonica.
by: Xiao Zhu, et al.
Published: (2014-01-01)